Guest post by Lawrence Sellin and Anna Chen
China’s People’s Liberation Army believes that biological weapons, not nuclear weapons, are the key to global military domination.
In our recent Gateway Pundit Article, we described the Chinese military publications of 2005 and 2006 by Colonel Ji-wei Guo, who advocated the use of biotechnology for the development of new methods of warfare and recommended that military medical doctors be involved in the creation of bioweapons.
In his 2008 book, “Biological Prospects for War and Predicting the Dominance of Biotechnology”, Colonel Guo elaborated on the application of biotechnology in bio-based warfare, representing the “third leap” in military strategy:
The third leap includes biotechnology and related sciences that are evolving and growing based on information technology (including advanced computing and communications), nanoscience and other convergence technologies, where biotechnology and biomedical science (including genetic engineering), cognitive science ( including cognitive neuroscience) is widely applied. It will cause major quantitative changes in the combat environment, combat methods, space-time relationship, military structure and function, and eventually cause new qualitative changes, which will bring about drastic changes in modern military history. The operational level change brought about by this military transformation is the further expansion of the theory of power control with modern biotechnology as the most important feature. ”
Colonel Guo’s remarks not only represented the incidental speculations of a particular Chinese military officer, but were concepts that were embraced by the People’s Liberation Army of China and embedded in his military doctrine.
In his 2012 article “Development of Military Biotechnology and the Future of Bio-Based Warfare,” Major General Fu-Chu He wrote:
‘As an emerging technology, military biotechnology expands the concept of weapons and equipment and becomes an important driver behind the development of weapons and equipment. In recent years, major breakthroughs have been made in many areas of military biotechnology, such as synthetic biology, brain-computer interface and brain control, biological materials, bio-inspired machinery, biofuels, bio-electronics, bio-computers and non-lethal weapons, leading to the birth of new operational concepts. In future wars, military biotechnology will advance the bio-based weapons and equipment, bio-based forces and bio-based fighting style. ”
Major General Fu-Chu He was President of the Academy of Military Medical Sciences, Vice President of China’s Academy of Medical Sciences, and Local member of the 18th Central Committee of the Chinese Communist Party and Deputy Director of Scientific and Technical Committee attached to the Central Military Commission, which is China’s equivalent of the US Department of Defense’s DARPA, the Defense Advanced Research Projects Agency.
Major General Chen Wei is currently the director of the Institute of Biotechnology, Academy of Military Medical Sciences and presumably head of China’s biological war program.
She is under command of the ‘clean-up’ operation in Wuhan after local authorities lost control of the COVID-19 outbreak. She also led China’s efforts to create a COVID-19 vaccine.
Published in 2014, Major General Chen Wei co-authored the book ‘Yearbook for Biotechnology Development, 2013’, which describes the most important biotechnological advances and their impact on military medical science.
The book contains 10 sections with 25 specific biotechnological topics including gene manipulation, synthetic biology, gene sequence, biotherapeutics, biomaterials, bioinformatics, bio-imaging, cloning and neurobiology.
In 2016, the Thirteenth Five-Year Plan’s Science and Technology Military Civilian Fusion Program launched by the Scientific and Technical Committee attached to the Central Military Commission.
This program included all Chinese universities, pharmaceutical companies, and ‘civilian’ research centers, such as the Wuhan Institute of Virology, in the People’s Liberation Army’s biotechnology warfare.
It is no surprise then that Major General Chen Wei’s predecessor as director of the Institute of Biotechnology and retired vice-president of the Academy of Military Medical Sciences, Major General Pei-Tang Huang a independent director from Hualan Biological Bacterin Inc. on April 26, 2019.
Given the intensity of the military-civilian research fusion program, it is perhaps no coincidence that the CEOs of twenty-three multinational and domestic pharmaceutical companies in China in the two to three months following the appointment of Pei-Tang Huang resigned or retired, including Sanofi, Roche, Bayer, Bristol-Myers Squibb and General Electric Healthcare.
In April 2021, Hualan Biological Bacterin Inc. announced an exclusive agreement with the Russian government to manufacture 100 million doses of the Sputnik V COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Ministry of Health.
None of the above has apparently caught the attention of those responsible for U.S. national security.
Clearly, the U.S. Department of Defense and U.S. intelligence agencies do not have a basic understanding of the direction and scope of China’s biotechnology warfare program.
U.S. government officials are unaware that COVID-19 was definitely an element of the program, perhaps even a test of it.
Lawrence Sellin, Ph.D. is a retired colonel of the U.S. Army and a veteran of Afghanistan and Iraq. He has had a civilian career in international affairs and medical research. His email address is [email protected]. Anna Chen can be followed on Twitter @ 2020Gladiator